Farther Finance Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $779 | Sell |
83
-40
| -33% | -$375 | ﹤0.01% | 3946 |
|
|
2025
Q1 | $819 | Buy |
123
+40
| +48% | +$266 | ﹤0.01% | 3675 |
|
|
2024
Q4 | $968 | Sell |
83
-35
| -30% | -$408 | ﹤0.01% | 3259 |
|
|
2024
Q3 | $2.43K | Sell |
118
-5
| -4% | -$103 | ﹤0.01% | 2926 |
|
|
2024
Q2 | $2.76K | Buy |
123
+29
| +31% | +$652 | ﹤0.01% | 2658 |
|
|
2024
Q1 | $2.56K | Sell |
94
-82
| -47% | -$2.23K | ﹤0.01% | 2385 |
|
|
2023
Q4 | $5.37K | Buy |
176
+162
| +1,157% | +$4.94K | ﹤0.01% | 1936 |
|
|
2023
Q3 | $443 | Sell |
14
-4
| -22% | -$127 | ﹤0.01% | 2303 |
|
|
2023
Q2 | $734 | Hold |
18
| – | – | ﹤0.01% | 2049 |
|
|
2023
Q1 | $671 | Hold |
18
| – | – | ﹤0.01% | 1931 |
|
|
2022
Q4 | $628 | Buy |
+18
| New | +$628 | ﹤0.01% | 1786 |
|